Kang Zheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kang Zheng has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Mengsheng Qiu
3 shared publicationsJunlin Yang
2 shared publications- Junlin Yang
College of Life and Environmental Sciences, Key Laboratory of Organ Development and Regeneration of Zhejiang Province, Hangzhou Normal University, Hangzhou, China
2 shared publications Yi Ai
2 shared publications- Bai Lu
School of Pharmaceutical Sciences and IDG/McGovern Institute for Brain Research, Tsinghua University, Beijing 100084, China; Institute of Biomedical Sciences, Fudan University, Shanghai 200032, China; Shanghai Academy of Natural Sciences, Shanghai 200031, China
1 shared publication Cheng He
1 shared publication
Latest Publications
- Open Access
- 2 September 2026
- Published by Elsevier in Cell Reports
- Vol. 45 (9)
Neuroinflammation induces aberrant activation of Wnt signaling in astrocytes and impairment of cholesterol homeostasis and myelin integrity
- 2 September 2026
- Published by Elsevier in Cell Reports
- Vol. 45 (9)
Open AccessNeuroinflammation induces aberrant activation of Wnt signaling in astrocytes and impairment of cholesterol homeostasis and myelin integrity
- Open Access
- 19 March 2026
- Published by Wiley in The FASEB Journal
- Vol. 40 (6) , e71710
UFMylation : A Key Role in Maintaining Endoplasmic Reticulum Homeostasis
UFMylation, a ubiquitin‐like post‐translational modification system, plays an essential role in regulating endoplasmic reticulum (ER) function. This process involves a cascade of biochemical reactions mediated by several core molecular components, including UFM1, the E1 enzyme UBA5, the E2 enzyme UFC1, the E3 enzyme UFL1, as well as the accessory proteins DDRGK1 and CDK5RAP3. During UFMylation, UFM1 undergoes maturation, activation, conjugation, and deconjugation in a dynamic process, whereas the ER‐localized UFL1‐DDRGK1 complex governs substrate selection and modification efficiency. The major function of UFMylation is to modulate the ER stress response, thereby balancing adaptive cellular remodeling and apoptotic signaling. Through the modification of key substrate proteins, UFMylation activates a synergistic clearance mechanism that coordinates ER‐phagy with ribosome‐associated quality control, thereby facilitating the removal of stalled ribosomes and damaged ER to maintain ER proteostasis and structural integrity. Dysregulation of UFMylation is frequently associated with various diseases characterized by abnormal ER function. In this review, we will describe the molecular pathways associated with ER‐associated UFMylation process and then discuss its core regulatory functions within the ER and its possible involvements in several congenital human diseases.
- 19 March 2026
- Published by Wiley in The FASEB Journal
- Vol. 40 (6) , e71710
Open AccessUFMylation : A Key Role in Maintaining Endoplasmic Reticulum Homeostasis
UFMylation, a ubiquitin‐like post‐translational modification system, plays an essential role in regulating endoplasmic reticulum (ER) function. This process involves a cascade of biochemical reactions mediated by several core molecular components, including UFM1, the E1 enzyme UBA5, the E2 enzyme UFC1, the E3 enzyme UFL1, as well as the accessory proteins DDRGK1 and CDK5RAP3. During UFMylation, UFM1 undergoes maturation, activation, conjugation, and deconjugation in a dynamic process, whereas the ER‐localized UFL1‐DDRGK1 complex governs substrate selection and modification efficiency. The major function of UFMylation is to modulate the ER stress response, thereby balancing adaptive cellular remodeling and apoptotic signaling. Through the modification of key substrate proteins, UFMylation activates a synergistic clearance mechanism that coordinates ER‐phagy with ribosome‐associated quality control, thereby facilitating the removal of stalled ribosomes and damaged ER to maintain ER proteostasis and structural integrity. Dysregulation of UFMylation is frequently associated with various diseases characterized by abnormal ER function. In this review, we will describe the molecular pathways associated with ER‐associated UFMylation process and then discuss its core regulatory functions within the ER and its possible involvements in several congenital human diseases.
- 3 October 2023
- Published by Wiley in Developmental Neurobiology
- Vol. 83 (7-8) , 282-292
Preparation of astrocytes by directed differentiation of pluripotent stem cells and somatic cell transdifferentiation
Astrocytes (ACs) are the most widely distributed cells in the mammalian central nervous system, which are essential for the function and homeostasis of nervous system. Increasing evidence indicates that ACs also participate in the development of many neurological diseases and repair after nerve injury. ACs cultured in vitro provide a cellular model for studying astrocytic development, function, and the pathogenesis of associated diseases. The preparation of primary ACs (pACs) faces many limitations, so it is important to obtain high‐quality ACs by the differentiation of pluripotent stem cell (PSC) or somatic cell transdifferentiation. Initially, researchers mainly tried to induce embryonic stem cells to differentiate into ACs via embryoid body (EB) and then turned to employ induced PSCs as seed cells to explore more simple and efficient directed differentiation strategies, and serum‐free culture was delved to improve the quality of induced ACs. While exploring the induction of ACs by the overexpression of AC‐specific transcription factors, researchers also began to investigate small molecule–mediated somatic cell transdifferentiation. Here, we provide an updated review on the research progresses in this field.
- 3 October 2023
- Published by Wiley in Developmental Neurobiology
- Vol. 83 (7-8) , 282-292
Preparation of astrocytes by directed differentiation of pluripotent stem cells and somatic cell transdifferentiation
Astrocytes (ACs) are the most widely distributed cells in the mammalian central nervous system, which are essential for the function and homeostasis of nervous system. Increasing evidence indicates that ACs also participate in the development of many neurological diseases and repair after nerve injury. ACs cultured in vitro provide a cellular model for studying astrocytic development, function, and the pathogenesis of associated diseases. The preparation of primary ACs (pACs) faces many limitations, so it is important to obtain high‐quality ACs by the differentiation of pluripotent stem cell (PSC) or somatic cell transdifferentiation. Initially, researchers mainly tried to induce embryonic stem cells to differentiate into ACs via embryoid body (EB) and then turned to employ induced PSCs as seed cells to explore more simple and efficient directed differentiation strategies, and serum‐free culture was delved to improve the quality of induced ACs. While exploring the induction of ACs by the overexpression of AC‐specific transcription factors, researchers also began to investigate small molecule–mediated somatic cell transdifferentiation. Here, we provide an updated review on the research progresses in this field.
- 10 January 2022
- Published by Wiley in Developmental Neurobiology
- Vol. 82 (2) , 149-159
Origin, molecular specification, and stemness of astrocytes
Astrocytes are the most abundant cell type in the central nervous system, carrying out a wide spectrum of biological functions. During early development, neural progenitor cells in the ventricular zone first produce neurons, followed by macroglia in the form of astrocytes or oligodendrocytes. Although the lineage progression of oligodendrocytes has been well understood, the developmental staging of astrocytes has not been defined and the molecular mechanisms underlying their fate specification and differentiation remain largely unknown. The recent advent of sophisticated molecular biology technology, especially single‐cell sequencing, has enabled a deeper understanding of the patterning and molecular specification of astrocyte lineage. Based on the recent single‐cell sequencing data, we provide an up‐to‐date and mechanistic review of the early development and heterogeneity of astrocyte lineage in the developing cortex, and compile a list of stage‐specific markers for astrocyte development. In addition, emerging evidence suggests that under physiological conditions, mature astrocytes are partially specialized progenitor cells that have functionally adapted to local neuronal microenvironment. Under pathological or injury conditions, astrocytes are capable of reentering cell cycles and differentiating into other neural cell types under the influence of both intrinsic factors and environmental cues.
- 10 January 2022
- Published by Wiley in Developmental Neurobiology
- Vol. 82 (2) , 149-159
Origin, molecular specification, and stemness of astrocytes
Astrocytes are the most abundant cell type in the central nervous system, carrying out a wide spectrum of biological functions. During early development, neural progenitor cells in the ventricular zone first produce neurons, followed by macroglia in the form of astrocytes or oligodendrocytes. Although the lineage progression of oligodendrocytes has been well understood, the developmental staging of astrocytes has not been defined and the molecular mechanisms underlying their fate specification and differentiation remain largely unknown. The recent advent of sophisticated molecular biology technology, especially single‐cell sequencing, has enabled a deeper understanding of the patterning and molecular specification of astrocyte lineage. Based on the recent single‐cell sequencing data, we provide an up‐to‐date and mechanistic review of the early development and heterogeneity of astrocyte lineage in the developing cortex, and compile a list of stage‐specific markers for astrocyte development. In addition, emerging evidence suggests that under physiological conditions, mature astrocytes are partially specialized progenitor cells that have functionally adapted to local neuronal microenvironment. Under pathological or injury conditions, astrocytes are capable of reentering cell cycles and differentiating into other neural cell types under the influence of both intrinsic factors and environmental cues.
- Open Access
- 29 July 2013
- Published by Oxford University Press (OUP) in Cerebral Cortex
- Vol. 24 (12) , 3277-3288
GABAergic Terminals Are a Source of Galanin to Modulate Cholinergic Neuron Development in the Neonatal Forebrain
The distribution and (patho-)physiological role of neuropeptides in the adult and aging brain have been extensively studied. Galanin is an inhibitory neuropeptide that can coexist with γ-aminobutyric acid (GABA) in the adult forebrain. However, galanin's expression sites, mode of signaling, impact on neuronal morphology, and colocalization with amino acid neurotransmitters during brain development are less well understood. Here, we show that galaninergic innervation of cholinergic projection neurons, which preferentially express galanin receptor 2 (GalR2) in the neonatal mouse basal forebrain, develops by birth. Nerve growth factor (NGF), known to modulate cholinergic morphogenesis, increases GalR2 expression. GalR2 antagonism (M871) in neonates reduces the in vivo expression and axonal targeting of the vesicular acetylcholine transporter (VAChT), indispensable for cholinergic neurotransmission. During cholinergic neuritogenesis in vitro, GalR2 can recruit Rho-family GTPases to induce the extension of a VAChT-containing primary neurite, the prospective axon. In doing so, GalR2 signaling dose-dependently modulates directional filopodial growth and antagonizes NGF-induced growth cone differentiation. Galanin accumulates in GABA-containing nerve terminals in the neonatal basal forebrain, suggesting its contribution to activity-driven cholinergic development during the perinatal period. Overall, our data define the cellular specificity and molecular complexity of galanin action in the developing basal forebrain.
- 29 July 2013
- Published by Oxford University Press (OUP) in Cerebral Cortex
- Vol. 24 (12) , 3277-3288
Open AccessGABAergic Terminals Are a Source of Galanin to Modulate Cholinergic Neuron Development in the Neonatal Forebrain
The distribution and (patho-)physiological role of neuropeptides in the adult and aging brain have been extensively studied. Galanin is an inhibitory neuropeptide that can coexist with γ-aminobutyric acid (GABA) in the adult forebrain. However, galanin's expression sites, mode of signaling, impact on neuronal morphology, and colocalization with amino acid neurotransmitters during brain development are less well understood. Here, we show that galaninergic innervation of cholinergic projection neurons, which preferentially express galanin receptor 2 (GalR2) in the neonatal mouse basal forebrain, develops by birth. Nerve growth factor (NGF), known to modulate cholinergic morphogenesis, increases GalR2 expression. GalR2 antagonism (M871) in neonates reduces the in vivo expression and axonal targeting of the vesicular acetylcholine transporter (VAChT), indispensable for cholinergic neurotransmission. During cholinergic neuritogenesis in vitro, GalR2 can recruit Rho-family GTPases to induce the extension of a VAChT-containing primary neurite, the prospective axon. In doing so, GalR2 signaling dose-dependently modulates directional filopodial growth and antagonizes NGF-induced growth cone differentiation. Galanin accumulates in GABA-containing nerve terminals in the neonatal basal forebrain, suggesting its contribution to activity-driven cholinergic development during the perinatal period. Overall, our data define the cellular specificity and molecular complexity of galanin action in the developing basal forebrain.